Themis Medicare [THEMISMED] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Themis Medicare Ltd.

NSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Themis Medicare Ltd. wins in 8 metrics, Innova Captab Ltd. wins in 12 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Themis Medicare Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 32.38 31.20 Innova Captab Ltd.
Price-to-Book Ratio 2.22 4.05 Themis Medicare Ltd.
Debt-to-Equity Ratio 25.15 32.95 Themis Medicare Ltd.
PEG Ratio 0.02 1.33 Themis Medicare Ltd.
EV/EBITDA -81.74 20.49 Innova Captab Ltd.
Profit Margin (TTM) -5.16% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 7.99% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) 7.99% 12.88% Innova Captab Ltd.
Return on Equity 7.41% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 5.07% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $192.84M $-1.09B Themis Medicare Ltd.
Dividend Yield 0.50% 0.30% Themis Medicare Ltd.
1-Year Return -24.55% 3.87% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 2.50 2.76 Themis Medicare Ltd.
Enterprise Value $9.17B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 2.72 2.90 Themis Medicare Ltd.
Gross Profit Margin (TTM) 67.63% 35.19% Themis Medicare Ltd.
Revenue per Share (TTM) $37 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $-1.89 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.06 -0.33 Innova Captab Ltd.

Themis Medicare Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

THEMISMED
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Themis Medicare Ltd.-1.04%-0.73%5.41%35.48%-1.86%3.09%
Innova Captab Ltd.0.58%8.95%10.45%34.08%34.58%28.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Themis Medicare Ltd.-24.55%-27.27%45.69%88.42%535.25%703.01%
Innova Captab Ltd.3.87%74.08%74.08%74.08%74.08%74.08%

Performance & Financial Health Analysis: Themis Medicare Ltd. vs Innova Captab Ltd.

MetricTHEMISMEDINNOVACAP
Market Information
Market Cap i₹8.57B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i75,711578,151
90 Day Avg. Volume i127,228217,693
Last Close₹102.91₹947.95
52 Week Range₹64.95 - ₹148.00₹622.00 - ₹978.00
% from 52W High-30.47%-3.07%
All-Time High₹1,834.00 (Sep 25, 2023)₹1,260.00 (Jan 06, 2025)
% from All-Time High-94.39%-24.77%
Growth Metrics
Quarterly Revenue Growth-0.04%0.42%
Quarterly Earnings Growth18.44%0.23%
Financial Health
Profit Margin (TTM) i-0.05%0.09%
Operating Margin (TTM) i0.08%0.13%
Return on Equity (TTM) i0.07%0.13%
Debt to Equity (MRQ) i25.1532.95
Cash & Liquidity
Book Value per Share (MRQ)₹40.99₹178.28
Cash per Share (MRQ)₹1.39₹10.22
Operating Cash Flow (TTM) i₹382.22M₹282.88M
Levered Free Cash Flow (TTM) i₹298.33M₹1.28B
Dividends
Last 12-Month Dividend Yield i0.50%0.30%
Last 12-Month Dividend i₹0.50₹2.00

Valuation & Enterprise Metrics Analysis: Themis Medicare Ltd. vs Innova Captab Ltd.

MetricTHEMISMED (Apr 22, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i32.3831.20
Forward P/E iN/A21.90
PEG Ratio i0.021.33
Price to Sales (TTM) i2.502.76
Price to Book (MRQ) i2.224.05
Market Capitalization
Market Capitalization i₹8.57B₹41.43B
Enterprise Value i₹9.17B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i2.722.90
Enterprise to EBITDA i-81.7420.49
Risk & Other Metrics
Beta i0.06-0.33
Book Value per Share (MRQ) i₹40.99₹178.28

Financial Statements Comparison: Themis Medicare Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTHEMISMED (2025)INNOVACAP (2025)
Revenue/Sales i4.00B12.34B
Cost of Goods Sold i1.34B8.38B
COGS % of Revenue i33.5%67.9%
Gross Profit i2.66B3.96B
Gross Margin i66.5%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i391.53M1.65B
Operating Margin i9.8%13.4%
EBITDA i581.30M2.00B
EBITDA Margin i14.5%16.2%
Pre-Tax Income i396.75M1.71B
Pre-Tax Income % of Revenue i9.9%13.9%
Income Tax i98.42M427.58M
Income Tax % of Revenue i2.5%3.5%
Net Income (Profit) i298.33M1.28B
Profit Margin i7.5%10.4%

Balance Sheet & Liquidity Metrics

MetricTHEMISMED (2025)INNOVACAP (2025)
Cash & Equivalents i65.59M155.19M
Total Current Assets i3.04B7.03B
Total Current Assets % of Revenue i76.0%57.0%
Total Current Liabilities i1.56B3.53B
Total Current Liabilities % of Revenue i39.0%28.6%
Long-Term Debt i186.12M2.45B
Long-Term Debt % of Revenue i4.7%19.8%
Total Shareholders Equity i4.03B9.59B
Retained Earnings i2.57B4.53B
Retained Earnings % of Revenue i64.3%36.7%
Property, Plant & Equipment i56.40M442.93M

Cash Flow Statement Comparison

MetricTHEMISMED (2025)INNOVACAP (2025)
Operating Cash Flow i382.22M282.88M
Operating Cash Flow % of Revenue i9.6%2.3%
Capital Expenditures i-137.44M-1.72B
Free Cash Flow i192.84M-1.09B
FCF Margin i4.8%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTHEMISMEDINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i92.10M57.22M
Float Shares i23.48M15.91M
% Held by Insiders i74.89%72.19%
% Held by Institutions i0.05%19.22%
% Held by Public i25.06%8.59%

Dividend Analysis & Yield Comparison: Themis Medicare Ltd. vs Innova Captab Ltd.

MetricTHEMISMEDINNOVACAP
Last 12-Month Dividend i₹0.50₹2.00
Last 12-Month Dividend Yield i0.50%0.30%
3-Year Avg Annual Dividend i₹0.37₹0.67
3-Year Avg Dividend Yield i0.18%0.30%
3-Year Total Dividends i₹1.10₹2.00
Ex-Dividend DateSep 04, 2025Jan 30, 2026